1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Patrick Reagan: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Brentuximab Vedotin, Rituximab, and Dose Attenuated CHP in Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Brentuximab vedotin, Rituximab, Cyclophosphamide - Diffuse Large B-Cell Lymphoma | Phase 2 | Active not recruiting | Patrick Reagan | 24 | 2016-06-01 | 2025-08-12 |
Lymphoma, Large B-Cell, Diffuse (1)
Brentuximab Vedotin (1) · Cyclophosphamide (1) · Doxorubicin (1) · Prednisone (1) · Rituximab (1) · liposomal doxorubicin (1)
United States (1)